BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15604942)

  • 21. Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.
    Maini CL; Tofani A; Sciuto R; Semprebene A; Cavaliere R; Mottolese M; Benevolo M; Ferranti F; Grandinetti ML; Vici P; Lopez M; Botti C
    J Nucl Med; 1997 Oct; 38(10):1546-51. PubMed ID: 9379190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
    Moustafa H; Riad R; Omar W; Zaher A; Ebied E
    Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic imaging: scintimammography.
    Salvatore M; Del Vecchio S
    Eur J Radiol; 1998 May; 27 Suppl 2():S259-64. PubMed ID: 9652532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake.
    Fuster D; Muñoz M; Pavia J; Palacín A; Bellet N; Mateos JJ; Martín F; Ortega M; Setoain FJ; Pons F
    Nucl Med Commun; 2002 Jan; 23(1):31-8. PubMed ID: 11748435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
    Collarino A; de Koster EJ; Valdés Olmos RA; de Geus-Oei LF; Pereira Arias-Bouda LM
    Clin Breast Cancer; 2018 Feb; 18(1):9-18. PubMed ID: 28728876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prognostic Impact of Early Change in 18F-FDG PET SUV After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer.
    Lee HW; Lee HM; Choi SE; Yoo H; Ahn SG; Lee MK; Jeong J; Jung WH
    J Nucl Med; 2016 Aug; 57(8):1183-8. PubMed ID: 27033896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.
    Akgun A; Cok G; Karapolat I; Goksel T; Burak Z
    Ann Nucl Med; 2006 May; 20(4):269-75. PubMed ID: 16856570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 99mTc-sestamibi uptake and histological malignancy grade in invasive breast carcinoma.
    Danielsson R; Sánchez-Crespo A; Pegerfalk A; Grabowska H; Larsson SA; Boné B; Aspelin P
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):662-6. PubMed ID: 12616323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tentative results of using 99mTC-methoxyisobutyl isonitrile in predicting the effect of preoperative chemotherapy for locally advanced breast cancer].
    Portnoĭ SM; Odzharova AA; Shiriaev SV; Anurova OA; Laktionov KP; Riabchikov DA
    Vopr Onkol; 2006; 52(6):620-3. PubMed ID: 17338237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer.
    Kwong MS; Chung GG; Horvath LJ; Ward BA; Hsu AD; Carter D; Tavassoli F; Haffty B; Burtness BA
    Cancer J; 2006; 12(3):212-21. PubMed ID: 16803680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
    Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
    Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.
    Tiling R; Kessler M; Untch M; Sommer H; Linke R; Brinkbäumer K; Hahn K
    Onkologie; 2003 Feb; 26(1):27-31. PubMed ID: 12624514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semi-quantitative assessment of 99Tcm-sestamibi uptake in lung cancer: relationship with clinical response to chemotherapy.
    Ceriani L; Giovanella L; Bandera M; Beghe B; Ortelli M; Roncari G
    Nucl Med Commun; 1997 Nov; 18(11):1087-97. PubMed ID: 9423210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer.
    Champion L; Lerebours F; Alberini JL; Fourme E; Gontier E; Bertrand F; Wartski M
    J Nucl Med; 2015 Sep; 56(9):1315-21. PubMed ID: 26159587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 99Tcm-MIBI scintimammography in 300 consecutive patients: factors that may affect accuracy.
    Tofani A; Sciuto R; Semprebene A; Festa A; Pasqualoni R; Giunta S; Mottolese M; Benevolo M; Botti C; Maini CL
    Nucl Med Commun; 1999 Dec; 20(12):1113-21. PubMed ID: 10664992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sonographic evaluation of early-stage breast cancers that undergo neoadjuvant chemotherapy.
    Roubidoux MA; LeCarpentier GL; Fowlkes JB; Bartz B; Pai D; Gordon SP; Schott AF; Johnson TD; Carson PL
    J Ultrasound Med; 2005 Jul; 24(7):885-95. PubMed ID: 15972702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer.
    Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D
    Clin Breast Cancer; 2006 Feb; 6(6):511-7. PubMed ID: 16595034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
    von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
    J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts].
    Mulero F; Nicolás F; Castellón MI; Fuentes T; de la Cruz P; Roca V; Abad L; Nuño de La Rosa JA
    Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.